GOLDEN MEDITECH HOLDINGS LTD., a Hong Kong-based healthcare enterprise, and MD Anderson Cancer Center announced the creation of Cellenkos Inc., a start-up enterprise focused on umbilical cord blood derived T-regulatory cellular therapies. Cellenkos, to be based in Houston, is funded with an initial investment of $10 million with warrants to purchase an additional $10 million...
Elizabeth Comen originally set out to write a book about the wellness industry, but ended up writing a different book altogether.
